Hexoprenaline Hydrochloride

盐酸海索那林

Report date: 2021/12/16 10:56:43

Base Information

Drug NameHexoprenaline Hydrochloride
Drug Alias Name盐酸己双肾上腺素
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-2 adrenergic receptor agonists
TargetsBeta-2 adrenergic receptor
Therapy Area/IndicationsAsthma
Global Approved IndicationsAsthma
Approved Indications in ChinaAsthma
Original Approved Country/TerritoryMainland China
Original Approved Date1989/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesShaanxi Pharmaceutical Holding Group Shanhaidan Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAsthma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG